Carillo, Gabriel C.
HRN: 21-87-75 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/04/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/04/2022
09/10/2022
IV
2.25g
Q6H
T/C Sepsis; Covid Pneumonia Severe
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes